Skip to main content
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. — Investor Relations & Filings

Ticker · SRPT ISIN · US8036071004 LEI · 549300IKDPIED8J8IG21 US Manufacturing
Open in API
Filings indexed 1,059 across all filing types
Latest filing 2025-08-13 Board/Management Inform…
Country US United States of America
Listing US SRPT

About Sarepta Therapeutics, Inc.

https://www.sarepta.com/

Sarepta Therapeutics is a commercial-stage biopharmaceutical company that engineers precision genetic medicines for rare diseases. The company's research and development efforts are centered on RNA-targeted therapeutics and gene therapies, with a primary focus on treating rare neuromuscular and central nervous system disorders. Sarepta aims to accelerate the drug development process from discovery to patient application and is building significant gene therapy manufacturing capabilities to support its mission.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 12, 2025, reporting a departure of a senior executive (Bilal Arif) and related employment and consulting arrangements. The content focuses on management changes and severance agreements. There are no financial statements or detailed financial performance data. The primary subject is the change in senior management and related agreements, which fits the category of Board/Management Information (MANG). The document length is 4090 characters, which is consistent with a typical 8-K management change filing. Therefore, the appropriate classification is MANG with high confidence.
2025-08-13 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-13 English
4
Director's Dealing
2025-08-07 English
4
Director's Dealing
2025-08-07 English
4
Director's Dealing
2025-08-07 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC. Form S-8 is used to register securities to be offered under employee benefit plans, such as equity incentive plans and employee stock purchase plans. The document includes details about the registration of additional shares under existing plans, references to prior filings, exhibits related to the plans, and signatures of company officers and directors. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length (8663 characters) and content confirm it is a full registration statement, not a brief announcement or certification.
2025-08-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.